Abbott Laboratories (ETR: ABL)

Germany flag Germany · Delayed Price · Currency is EUR
108.10
-0.70 (-0.64%)
Dec 19, 2024, 5:35 PM CET
9.24%
Market Cap 190.20B
Revenue (ttm) 36.96B
Net Income (ttm) 5.15B
Shares Out n/a
EPS (ttm) 2.95
PE Ratio 36.93
Forward PE n/a
Dividend 2.02 (1.87%)
Ex-Dividend Date Oct 15, 2024
Volume 94
Open 108.62
Previous Close 108.80
Day's Range 107.48 - 108.62
52-Week Range 90.00 - 114.14
Beta 0.72
Analysts n/a
Price Target n/a
Earnings Date Jan 22, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1888
Employees 114,000
Stock Exchange Deutsche Börse Xetra
Ticker Symbol ABL
Full Company Profile

Financial Performance

In 2023, Abbott Laboratories's revenue was $40.11 billion, a decrease of -8.12% compared to the previous year's $43.65 billion. Earnings were $5.70 billion, a decrease of -17.44%.

Financial numbers in USD Financial Statements

News

Abbott Laboratories Unveils Groundbreaking Leadless Pacemaker Technology

Abbott Laboratories Unveils Groundbreaking Leadless Pacemaker Technology

4 days ago - GuruFocus

Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart

Abbott's investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural condu...

4 days ago - PRNewsWire

Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value

Concentrate on a select few high-conviction stocks across different sectors to avoid "diworsification" and maximize returns, inspired by Charlie Munger and Warren Buffett. Utilize Joel Greenblatt's "M...

7 days ago - Seeking Alpha

Abbott Laboratories raises dividend by 7.3% to $0.59

Abbott Laboratories (ABT) increases quarterly dividend by 7.3% to $0.59/share, marking 53rd consecutive year of dividend growth.

8 days ago - Seeking Alpha

Abbott Laboratories Increases Quarterly Dividend for 53rd Consecutive Year

Abbott Laboratories Increases Quarterly Dividend for 53rd Consecutive Year

8 days ago - GuruFocus

Abbott Increases Quarterly Dividend for 53rd Consecutive Year

Dividend increased by 7.3% Quarterly dividend payout has increased more than 60% since 2020 404th consecutive quarterly dividend to be paid by Abbott since 1924 ABBOTT PARK, Ill., Dec. 13, 2024 /PRNew...

8 days ago - PRNewsWire

Dow Tumbles 200 Points; Liquidity Services Shares Spike Higher

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 200 points on Thursday. The Dow traded down 0.46% to 43,947.18 while the NASDAQ fell 0.38% to 19,957.81. The...

8 days ago - Benzinga

Gold Falls Sharply; Adobe Shares Dip After Weak Revenue Outlook

U.S. stocks traded lower midway through trading, with the Dow Jones index falling by 0.2% on Thursday. The Dow traded down 0.18% to 44,067.70 while the NASDAQ fell 0.33% to 19,969.33. The S&P 500 also...

8 days ago - Benzinga

Nasdaq Down 50 Points; US Initial Jobless Claims Rise

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Thursday. Following the market opening Thursday, the Dow traded down 0.01% to 44,142.13 while the...

9 days ago - Benzinga

Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them

On CNBC's “ Mad Money Lightning Round ,” Jim Cramer said Occidental Petroleum (NYSE: OXY) is one of his “least favorite oils.” On Monday, UBS analyst Josh Silverstein maintained Occidental Petroleum ...

10 days ago - Benzinga

Lightning Round: Abbott Labs' legal trouble is largely behind it, says Jim Cramer

'Mad Money' host Jim Cramer weighs in on stock including: Occidental Petroleum, Cooper Companies, Energy Transfer, Eli Lilly, Abbott Labs, Kinder Morgan, and more.

10 days ago - CNBC

Abbott Laboratories and Big Ten's Blood Drive Competition: A Lifesaving Success

Abbott Laboratories and Big Ten's Blood Drive Competition: A Lifesaving Success

13 days ago - GuruFocus

University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott

Nearly 20,000 Big Ten students, alumni and fans across the country donated blood as part of the Abbott-Big Ten nationwide competition this college football season, helping save as many as 60,000 lives...

13 days ago - PRNewsWire

Judge denies Abbott request for retrial, lower damages in $500M baby formula case

Missouri judge denies Abbott Laboratories (ABT) new trial request after $500 million infant formula case verdict.

24 days ago - Seeking Alpha

The Best Large-Cap Stocks to Buy

Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here.

24 days ago - Kiplinger

Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis

The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart valve disease The inves...

26 days ago - PRNewsWire

Abbott Laboratories: Investors Should Wait For A Pullback

Abbott Laboratories' revenue and return on invested capital could be more consistent. Read why potential investors will need to be patient with ABT stock.

26 days ago - Seeking Alpha

Tech giants stumble: Communication services slump amid mixed market signals

Sector Overview The stock market is showcasing a mixed bag of performances today, characterized by a notable decline in communication services, while some tech giants experience pressure. Simultaneous...

4 weeks ago - Forexlive

MACH Alliance Expands Education Program, Appoints Dylan Valade of Abbott As Head of Education

NEW YORK--(BUSINESS WIRE)--MACH Alliance, a not-for-profit industry body dedicated to advocating for open, best-of-breed technology ecosystems, today announced the expansion of its thriving education ...

4 weeks ago - Business Wire

Abbott Laboratories (ABT) Extends Executive Change in Control Agreements

Abbott Laboratories (ABT) Extends Executive Change in Control Agreements

5 weeks ago - GuruFocus

Abbott Laboratories Employees Credit Union ("ALECU") Data Breach - Levi & Korsinsky, LLP Launches Investigates

NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of custom...

6 weeks ago - Accesswire

Abbott India posts Q2 profit rise on strong demand, price hikes

Drugmaker Abbott India reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications.

6 weeks ago - Reuters

Levi & Korsinsky, LLP Investigates Abbott Laboratories Employees Credit Union ("ALECU") Data Breach

NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of custom...

6 weeks ago - Accesswire

Levi & Korsinsky, LLP Investigates Abbott Laboratories Employees Credit Union ("ALECU") Data Breach

NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Abbott Laboratories Employees Credit Union ("ALECU")recently disclosed a data breach that compromised the sensitive personal data of thousands of custome...

6 weeks ago - Accesswire

The lawsuits against Abbott 'really steam me', says Jim Cramer

'Mad Money' host Jim Cramer takes a closer look at the litigation facing Abbott Labs.

7 weeks ago - CNBC Television